Introduction
The detailed epidemiology of invasive Group C and Group G Streptococcal (iGCS/GGS) in England has not previously been investigated. Given longitudinal increases in these pathogens,[1] we assessed patterns of disease to prioritise development of healthcare and public health interventions.
Methods
Invasive (sterile-site) GCS/GGS data between 01/01/2016 and 31/12/2023 for England were extracted from UKHSA’s national laboratory reporting database,[2] then augmented through linkage to capture hospital acquisition,[3] ethnicity,[4] and socioeconomic deprivation.[5][6] Hospital acquired infection (HAI) was defined as iGCS/GGS specimen taken ≥3-days after hospital admission. Residential clusters were defined as ≥2 cases within 90-days from the same residential postcode.
Results
Between 2016 and 2023, 24,711 iGCS/GGS were reported in England; median age: 77yrs (IQR: 65-86yrs), 54.2% (n=13,395) male). Annual rates of iGCS/GGS increased 25% (4.6 to 5.8/100,000 population) between 2016 and 2022, peaking in 2019 (6.2/100,000).
iGCS/GGS was more frequently identified in patients living in the most-deprived quintile of the country (22.5%; n=5551), with 0.2% (n=160) cases having no fixed abode. A total of 518 residential clusters were identified (median 2 per-cluster; maximum 6 cases), with a median of 41-days between cases (IQR: 21-63-days). iGCS/GGS annual incidence was 4-fold higher in people of white versus black ethnicity.
HAI was identified in 4% cases (n=941), increasing from 3.9% in 2016 to 4.9% in 2022.
Discussion
This first in-depth national study on iGCS/GGS in England and highlights differences amongst patients with reported iGCS/GGS, with variation by ethnicity. Further investigation of household risk and clustering is needed to identify opportunities for prevention.